Alpha 2.0
Login Register
» Authors » Pengliang Xin

Pengliang Xin

Explore the profile of Pengliang Xin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 48
Followers 0
Related Specialties
General Medicine
Oncology
Geriatrics
Top 10 Co-Authors
Chuntuan Li
Yan Zheng
Xiongpeng Zhu
Qunyi Peng
Shengquan Liu
YuanLing Huang
Huifang Xiao
Yahong Xu
Hongjun Lin
Tingjin Zheng
Published In
Aging (Albany NY)
Cancer Cell Int
Med Sci Monit
J Vis Exp
Drug Des Devel Ther
Affiliations
Soon will be listed here.
Recent Articles
1.
A Comprehensive Approach to Analyze the Cell Components of Cerebral Blood Clots
Lin W, Lin H, Xin P, Yan H, Kang B, Tang M
J Vis Exp . 2023 Aug; (197). PMID: 37590538
Cerebral thrombosis, a blood clot in a cerebral artery or vein, is the most common type of cerebral infarction. The study of the cell components of cerebral blood clots is...
2.
APDL1-CART cells exhibit strong PD-L1-specific activity against leukemia cells
Peng Q, Zhu X, Li C, Xin P, Zheng Y, Liu S
Aging (Albany NY) . 2021 Mar; 13(5):7199-7210. PMID: 33653969
Chimeric antigen receptor (CAR) T cells target specific tumor antigens and lyse tumor cells in an MHC-independent manner. However, the efficacy of CAR-T cell and other cancer immunotherapies is limited...
3.
Calreticulin increases growth and progression of natural killer/T-cell lymphoma
Zheng Y, Li C, Xin P, Peng Q, Zhang W, Liu S, et al.
Aging (Albany NY) . 2020 Nov; 12(23):23822-23835. PMID: 33221760
In this study, we investigated the role of calreticulin (CALR) in the pathogenesis of natural killer/T-cell lymphoma (NKTCL). CALR expression was significantly higher in the NKTCL tissues than normal control...
4.
Role and mechanism of PTEN in Burkitt's lymphoma
Li C, Xu Y, Xin P, Zheng Y, Zhu X
Oncol Rep . 2020 Jan; 43(2):481-490. PMID: 31922234
The aim of the present study was to explore the possible mechanisms of phosphatase and tensin homolog (PTEN) in the pathogenesis of Burkitt's lymphoma, and provide novel information that can...
5.
Sonidegib, a Smoothened Inhibitor, Promotes Apoptosis and Suppresses Proliferation of Natural Killer/T-Cell Lymphoma
Liu S, Li C, Xin P, Zheng Y, Peng Q, Xu Y, et al.
Med Sci Monit . 2019 Nov; 25:8579-8586. PMID: 31724562
BACKGROUND Dysregulation of the Hedgehog (Hh) pathway modulates various aspects of hematologic and solid tumors, but its effects in human Natural killer/T-cell lymphoma (NKTCL) are unclear. Moreover, no study has...
6.
Protective autophagy or autophagic death: effects of BEZ235 on chronic myelogenous leukemia
Xin P, Xu W, Zhu X, Li C, Zheng Y, Zheng T, et al.
Cancer Manag Res . 2019 Nov; 11:7933-7951. PMID: 31686909
Purpose: To investigate the effects of BEZ235 on chronic myeloid leukemia (CML) cells. Methods: MTS assay was used to detect the proliferation of CML cells. The proteins expression were detected...
7.
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines
Xin P, Li C, Zheng Y, Peng Q, Xiao H, Huang Y, et al.
Drug Des Devel Ther . 2017 Apr; 11:1115-1126. PMID: 28435223
Background: Phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is a therapy target of cancer. We aimed to confirm the effect of dual PI3K/mTOR inhibitor NVP-BEZ235 on proliferation, apoptosis, and autophagy...
8.
The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells
Li C, Xin P, Xiao H, Zheng Y, Huang Y, Zhu X
Cancer Cell Int . 2015 Jul; 15:65. PMID: 26130968
Background: Phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is a therapy target of cancer. We aimed to confirm the effect of dual PI3K/mTOR inhibitor NVP-BEZ235 on cell proliferation and apoptosis...